Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.
2.
3.

Targeting Pseudomonas exotoxin to hematologic malignancies.

Kreitman RJ, Pastan I.

Semin Cancer Biol. 1995 Oct;6(5):297-306. Review.

PMID:
8562907
4.

Recombinant immunotoxins for the treatment of Hodgkin's disease (Review).

Matthey B, Engert A, Barth S.

Int J Mol Med. 2000 Nov;6(5):509-14. Review.

PMID:
11029515
5.

Recombinant immunotoxins.

Pastan I, Pai LH, Brinkmann U, FitzGerald D.

Breast Cancer Res Treat. 1996;38(1):3-9. Review.

PMID:
8825117
6.

Recombinant single-chain immunotoxins against T and B cell leukemias.

Kreitman RJ, Pastan I.

Leuk Lymphoma. 1994 Mar;13(1-2):1-10. Review.

PMID:
8025511
7.

Recombinant antibody fragments and immunotoxin fusions for cancer therapy.

Brinkmann U.

In Vivo. 2000 Jan-Feb;14(1):21-7. Review.

PMID:
10757057
8.

Targeted therapy of cancer with recombinant immunotoxins.

Pastan I.

Biochim Biophys Acta. 1997 Oct 24;1333(2):C1-6. Review. No abstract available.

PMID:
9395287
9.
10.

Immunoconjugates of Pseudomonas exotoxin A: evaluation in mice, monkeys, and man.

Morgan AC Jr, Manger R, Pearson JW, Longo D, Abrams P, Sivam G, Bjorn M.

Cancer Detect Prev. 1991;15(2):137-43. Review.

PMID:
2032255
11.

Targeted anticancer immunotoxins and cytotoxic agents with direct killing moieties.

Kawakami K, Nakajima O, Morishita R, Nagai R.

ScientificWorldJournal. 2006 Jul 7;6:781-90. Review.

12.
13.

Pseudomonas exotoxin: recombinant conjugates as therapeutic agents.

FitzGerald DJ, Pastan I.

Biochem Soc Trans. 1992 Nov;20(4):731-4. Review. No abstract available.

PMID:
1487051
14.

The performance of e23(Fv)PEs, recombinant toxins targeting the erbB-2 protein.

King CR, Fischer PH, Rando RF, Pastan I.

Semin Cancer Biol. 1996 Apr;7(2):79-86. Review.

PMID:
8740563
15.

[Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].

Chiron MF.

Bull Cancer. 1997 Dec;84(12):1135-40. Review. French.

16.

Quantification of immunotoxin number for complete therapeutic response.

Kreitman RJ.

Methods Mol Biol. 2001;166:111-23. Review. No abstract available.

PMID:
11217362
17.

Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Kreitman RJ.

BioDrugs. 2009;23(1):1-13. doi: 10.2165/00063030-200923010-00001. Review.

18.

Immunotoxins in the treatment of refractory hairy cell leukemia.

Kreitman RJ, Pastan I.

Hematol Oncol Clin North Am. 2006 Oct;20(5):1137-51, viii. Review.

PMID:
16990113
19.

Toxin-labeled monoclonal antibodies.

Kreitman RJ.

Curr Pharm Biotechnol. 2001 Dec;2(4):313-25. Review.

PMID:
11762413
20.

Immunotoxins and recombinant toxins in the treatment of solid carcinomas.

Theuer CP, Pastan I.

Am J Surg. 1993 Sep;166(3):284-8. Review.

PMID:
8368439
Items per page

Supplemental Content

Support Center